Bullseye Breakdown - Ep. 111 - Brian Feth - Scaling Cell Therapy and Using AI to Fight Cancer

What if cancer could be treated using your own supercharged immune cells?

In this episode ofBullseye Breakdown, hostDustin Weaversits down withBrian Feth, CEO ofXcellbio, to unpack the future of cancer treatment throughimmune cell therapy,AI-driven potency testing, andscalable biotech manufacturing.

We cover:

• How CAR-T therapies are shifting from “last resort” to front-line treatment

• Why scaling biotech is like surgery — not software

• How AI and impedance readers are changing the way we measure cancer-fighting potency

• Building a platform that helps cure patientsandgenerate revenue before FDA approval

• The emotional toll of biotech — and how to lead through it

Brian also shares the worst advice he ever received, and how his team has built a company that’s saving lives — and scaling with grit.

If you care aboutcancer research,biotech startups, or what it takes to grow a mission-driven business in a brutal industry, this one’s a must-listen.

🎯Follow Bullseye Breakdownfor unfiltered founder stories that aim higher.